Awards and Honors

1983–1985: Bressler Fund
"Cholesterol Oxide Atherogenesis in White Carneau Pigeons."

1984–1987: HHS Maternal and Child Health  (3 years)
"Trauma Recovery Process in Adolescents with Closed Head Injury."  Co-investigator (P.I., -F.P. Heald)

1986:    Long Island Jewish Medical Center, Competitive Pool Award "Cholesterol Oxides and Atherosclerosis"

1986–1987:   American Heart Association Nassau County -
"Cholesterol Oxides and Atherosclerosis"

1986–1988:   S.L.E. Foundation Dyslipoproteinemia in Pediatric S.L.E. (co PI: N Ilowite  M.D.)

1987:   Elected Fellow - Council on Arteriosclerosis, American Heart Association

1988–1992:  Long Island Jewish Medical Center Board of Directors, Investigations into growth of hyperlipidemic children

1990–1991:   Merck Sharpe and Dohme,  Lovastatin-Adolescent Study


^ Back to Top


1993:   SLE Foundation, Dyslipoproteinemia in SLE
(Co P.I. with Norman Ilowite, M.D.)

1994–1997:   New York State Department of Health,
Healthy Hearts Program

2000:   American Heart Association, New York City Affiliate.

1998:   Primary Care Intervention for Prevention of Pediatric Obesity,

1998:   March of Dimes, Integration of Reproductive screening in Pediatric Practice (R.Koppel, P.I.)

1998:   Millennium Pharmaceuticals Boston Children’s Hospital, Genetic Determinants of HDL-Cholesterol

1999:   Merck   Lovastatin Adolescent Females Trial

2000:   American Heart Association NY Affiliate,  Multidisciplinary Evaluation of a screening tool  for Pediatric Obesity

2000–2002:   NIH  RAR-98-071,   Alendronate for Treatment of Osteopenia in Anorexia Nervosa (co investigator, P.I. Neville Golden MD)

2000–2002:   Roche,   Double blind placebo controlled trial of Xenical in adolescent obesity.


^ Back to Top


2003:   Merck,  Randomized Trial of Atorvastatin vs. Simvistatin and Ezetimibe in Adolescents with Familial Hypercholesterolemia.

2005:   Schering Plough, Randomized Trial of Simvastatin vs.   Simvastatin-Ezetimibe in 12-17 year olds with Familial Hypercholesterolemia.

2005–2007:   Sankyo Pharmaceuticals, Randomized Trial of Colesevelam in Adolescents with Familial Hypercholesterolemia.

2005:   Davis Foundation, Three month visiting professorship in Pediatric Lipids (O. Hamiel MD PI)

2007:   Astra Zeneca,  Randomized Placebo Controlled Trial of Rosuvastatin in Familial Hypercholesterolemia.

^ Back to Top